Xenon Pharmaceuticals to Present at Stifel 2022 CNS Days

Rhea-AI Summary

Xenon Pharmaceuticals (Nasdaq:XENE) announced participation in the Stifel 2022 CNS Days virtual conference on March 29, 2022. Management will engage in one-on-one investor meetings and a fireside chat from 11:00-11:25 am Eastern Time. Presenters include Ian Mortimer, President and CEO, and Chris Von Seggern, Chief Commercial Officer.

The company focuses on developing innovative therapeutics for neurological disorders and has a pipeline aimed at addressing high unmet medical needs, particularly in epilepsy.

BURNABY, British Columbia, March 22, 2022 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced that management will participate in one-on-one investor meetings and a fireside chat at the Stifel 2022 CNS Days (virtual) conference.

Fireside Chat Details:

Date:		Tuesday, March 29, 2022
Time:		11:00-11:25 am Eastern Time
Presenters:		Ian Mortimer, President and CEO and Chris Von Seggern, Chief Commercial Officer

Details on company presentations and webcasts can be found on the “Investors” section of Xenon’s website at investor.xenon-pharma.com. When available, webcasts will be posted for replay following the event. The above listed dates and times are subject to change.

About Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals (NASDAQ:XENE) is a clinical stage biopharmaceutical company committed to developing innovative therapeutics to improve the lives of patients with neurological disorders. We are advancing a novel product pipeline of neurology therapies to address areas of high unmet medical need, with a focus on epilepsy. For more information, please visit www.xenon-pharma.com.

“Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

Investor/Media Contact:
Jodi Regts
Xenon Pharmaceuticals Inc.
Phone: 604.484.3353
Email: investors@xenon-pharma.com

FAQ

When is the Xenon Pharmaceuticals fireside chat during the Stifel 2022 CNS Days conference?

The fireside chat is scheduled for March 29, 2022, from 11:00-11:25 am Eastern Time.

Who will present during the Xenon Pharmaceuticals fireside chat?

Ian Mortimer, President and CEO, and Chris Von Seggern, Chief Commercial Officer, will present.

What is the main focus of Xenon Pharmaceuticals (XENE)?

Xenon Pharmaceuticals focuses on developing innovative therapeutics for neurological disorders, particularly epilepsy.

Where can I find more information about Xenon Pharmaceuticals' conference presentations?

More information can be found on Xenon's 'Investors' section at investor.xenon-pharma.com.

Is the Stifel 2022 CNS Days conference virtual?

Yes, the Stifel 2022 CNS Days conference is being held virtually.